Retinopathy and clinical outcomes in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia

Authors

Natalie A. Bello, Brigham and Women's Hospital
Marc A. Pfeffer, Brigham and Women's Hospital
Hicham Skali, Brigham and Women's Hospital
Janet B. McGill, Washington University School of Medicine in St. Louis
Jerome Rossert, Amgen
Kurt A. Olson, Amgen
Larry Weinrauch, Brigham and Women's Hospital
Mark E. Cooper, Baker IDI Heart & Diabetes Institute
Dick de Zeeuw, University of Groningen
Peter Rossing, Unversity of Aarhus
John J. V. McMurray, University of Glasgow
Scott D. Solomon, Brigham and Women's Hospital
Trial to Reduce cardiovascular Events with Aranesp Therapy (TREAT) Investigators

Journal

BMJ Open Diabetes Research & Care

Publication Date

2014

Volume

2

Issue

1

Inclusive Pages

e000011

Document Type

Open Access Publication

DOI

10.1136/bmjdrc-2013-000011

Rights and Permissions

Bello NA, Pfeffer MA, Skali H, et al. Retinopathy and clinical outcomes in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia. BMJ Open Diabetes Research and Care 2014;2:e000011. doi:10.1136/bmjdrc-2013-000011 This article was published in BMJ Open following peer review and can also be viewed on the journal’s website at http://bmjopen.bmj.com.

Recommended Citation

Bello, Natalie A.; Pfeffer, Marc A.; Skali, Hicham; McGill, Janet B.; Rossert, Jerome; Olson, Kurt A.; Weinrauch, Larry; Cooper, Mark E.; de Zeeuw, Dick; Rossing, Peter; McMurray, John J. V.; Solomon, Scott D.; and Trial to Reduce cardiovascular Events with Aranesp Therapy (TREAT) Investigators, "Retinopathy and clinical outcomes in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia." BMJ Open Diabetes Research & Care. 2, 1. e000011. (2014).
https://digitalcommons.wustl.edu/open_access_pubs/3504